Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (81-90 of 332) with videos related to

Pageof 34
Sort By:
Cancers|January 8, 2023
Blinatumomab in Relapsed/Refractory Burkitt LymphomaJeanne Bohler, Ulrike Bacher, Yara Banz, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell LymphomaKatja Seipel, Michèle Frey, Henning Nilius, et al.
Bone Marrow Transplantation|December 5, 2019
Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemiaMartin Sula, Ulrike Bacher, Elisabeth Oppliger Leibundgut, et al.
Leukemia Research|December 19, 2009
Complexity of miR-223 regulation by CEBPA in human AMLMarianne Eyholzer, Sabine Schmid, Julian A Schardt, et al.
Current Issues in Molecular Biology|January 30, 2026
Elevated Allele Frequency and Male-Predominance of a Common <i>LAG3</i> Germline Variant in Multiple MyelomaKatja Seipel, Alina Mena, Pinar Horum, et al.
Cancers|April 26, 2025
Adherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple MyelomaValérie Gennheimer, Dilara Akhoundova, Michèle Hoffmann, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief ReportMichèle Hoffmann, Yara Banz, Jörg Halter, et al.
Biomedicines|June 26, 2026
Influence of <i>PPM1D</i> Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma PatientsElena Fiori, Martina Bertschinger, Ulrike Bacher, et al.
Hematological Oncology|November 23, 2019
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemiaAlexander D Heini, Rebecca Hugo, Martin D Berger, et al.
Journal of Clinical Medicine|February 27, 2026
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab EraJulia Bee, Inna Shaforostova, Michèle Hoffmann, et al.
Pageof 34

Showing results (81-90 of 332) with videos related to

Sort By:
Pageof 34
Cancers|January 8, 2023
Blinatumomab in Relapsed/Refractory Burkitt LymphomaJeanne Bohler, Ulrike Bacher, Yara Banz, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell LymphomaKatja Seipel, Michèle Frey, Henning Nilius, et al.
Bone Marrow Transplantation|December 5, 2019
Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemiaMartin Sula, Ulrike Bacher, Elisabeth Oppliger Leibundgut, et al.
Leukemia Research|December 19, 2009
Complexity of miR-223 regulation by CEBPA in human AMLMarianne Eyholzer, Sabine Schmid, Julian A Schardt, et al.
Current Issues in Molecular Biology|January 30, 2026
Elevated Allele Frequency and Male-Predominance of a Common <i>LAG3</i> Germline Variant in Multiple MyelomaKatja Seipel, Alina Mena, Pinar Horum, et al.
Cancers|April 26, 2025
Adherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple MyelomaValérie Gennheimer, Dilara Akhoundova, Michèle Hoffmann, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief ReportMichèle Hoffmann, Yara Banz, Jörg Halter, et al.
Biomedicines|June 26, 2026
Influence of <i>PPM1D</i> Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma PatientsElena Fiori, Martina Bertschinger, Ulrike Bacher, et al.
Hematological Oncology|November 23, 2019
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemiaAlexander D Heini, Rebecca Hugo, Martin D Berger, et al.
Journal of Clinical Medicine|February 27, 2026
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab EraJulia Bee, Inna Shaforostova, Michèle Hoffmann, et al.
Pageof 34